大腸がん分子診断の世界市場レポート 2024

大腸がん分子診断の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.0%の年間複合成長率（CAGR）で34億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、大腸がんの危険因子の増加を伴う高齢化、臨床実践へのゲノムデータの統合、精密医療アプローチの台頭、がん調査における世界の共同努力などの要因に起因すると考えられます。予測期間中に予想される主な動向には、早期検出バイオマーカーの重視の高まり、データ分析における人工知能（AI）の統合、循環腫瘍DNA（ctDNA）分析の卓越性、標的療法のためのコンパニオン診断の拡大、および免疫療法バイオマーカーへの注目が高まっています。これらの動向は、予測期間中に大腸がん分子診断の継続的な拡大を形成し、推進する態勢が整っています。

予想される炎症性腸疾患（IBD）の発生率の急増は、大腸がん分子診断市場の成長を推進する重要な推進力になると予測されています。 IBDは、消化管の炎症を特徴とする慢性胃腸障害であり、特に結腸と直腸に影響を及ぼします。 IBDの有病率の増加により、大腸がん（CRC）の全身療法を決定するために重要な、正確で高度な診断ソリューションが必要となります。腫瘍の分子評価は治療法の決定に大きく影響し、効率的な診断ソリューションの需要が高まります。 2021年5月のBioMed Central Ltd.によると、IBD症例は大幅に増加し、2020年から2035年までにイランで約6万9,000人、中東で22万人、インドで220万人、東アジアでは注目すべき450万人に達すると予想されています。 IBDの発生率は増加しており、大腸がん分子診断市場の成長を促進する態勢が整っています。

大腸がんの罹患率の拡大は、大腸がん分子診断市場の成長を促進すると予測されています。大腸がんは結腸または直腸に影響を及ぼし、これらの消化器系領域での細胞の制御されない増殖が原因で発生し、腫瘍形成を引き起こします。大腸がん症例の急増により、がんの検出と治療に不可欠な分子診断ツールの需要が高まっています。 2023年 3月に米国がん協会が強調したように、推定153,020人が大腸がんの診断を受けると予想され、約52,550人が死亡すると予測されています。この予測には、50歳未満の感染者数19,550人と死亡者数3,750人が含まれています。したがって、大腸がんの罹患率の上昇は、大腸がん分子診断市場の成長を促進する重要な原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の大腸がん分子診断市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 機器
• 試薬とキット
• サービス
• 世界の大腸がん分子診断市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ポリメラーゼ連鎖反応（PCR）
• シーケンス
• 質量分析法
• 転写媒介増幅
• チップとマイクロアレイ
• 等温核酸増幅技術（INAAT）
• 世界の大腸がん分子診断市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 外来手術センター
• 診断研究所
• 在宅ケア環境

第7章 地域および国の分析

• 世界の大腸がん分子診断市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の大腸がん分子診断市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 大腸がん分子診断市場の競合情勢
• 大腸がん分子診断市場の企業プロファイル
  • Johnson &Johnson
  • Bayer AG
  • Abbott Laboratories
  • Danaher Corporation
  • Becton Dickinson and Company

第31章 その他の大手および革新的な企業

• Biocartis Group NV
• Agilent Technologies Inc.
• Grifols SA
• Hologic Inc.
• Biomerieux SA
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Exact Sciences Corporation
• Illumina Inc.
• Cepheid
• Myriad Genetics Inc.
• Guardant Health
• Luminex Corporation
• GenMark Diagnostics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Colorectal cancer, also known as colon cancer or rectal cancer, is a malignant tumor that forms in the colon (large intestine) or rectum (final part of the digestive tract before the anus). It originates from the inner lining of these gastrointestinal segments. Colorectal cancer molecular diagnostics involve advanced techniques to identify specific genetic mutations, alterations, and biomarkers crucial for understanding the development, progression, and treatment response of colorectal cancer.

The primary components of colorectal cancer molecular diagnostics include instruments, reagents, kits, and services. Instruments are specialized tools or devices designed for analyzing and detecting molecular changes, such as genetic mutations, variations in gene expression, or specific biomolecules, within biological samples from patients with colorectal cancer. Molecular diagnostic solutions employ technologies such as polymerase chain reaction (PCR), sequencing, mass spectrometry, transcription-mediated amplification, chips and microarrays, and isothermal nucleic acid amplification technology (INAAT). These diagnostics are utilized by various end-users, including hospitals, ambulatory surgical centers, diagnostic laboratories, and homecare settings.

The colorectal cancer molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer molecular diagnostics market statistics, including colorectal cancer molecular diagnostics industry global market size, regional shares, competitors with a colorectal cancer molecular diagnostics market share, detailed colorectal cancer molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer molecular diagnostics industry. This colorectal cancer molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer molecular diagnostics market size has grown strongly in recent years. It will grow from $2.35 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historical period can be attributed to several factors, including the increasing incidence of colorectal cancer, heightened awareness and screening initiatives, a growing emphasis on personalized medicine, and government initiatives focused on cancer control. These factors collectively contributed to the expansion of colorectal cancer molecular diagnostics during the historic period.

The colorectal cancer molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.48 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The anticipated growth in the forecast period can be attributed to factors such as an aging population with increased risk factors for colorectal cancer, the integration of genomic data into clinical practices, the rise of precision medicine approaches, and global collaborative efforts in cancer research. Key trends expected in the forecast period encompass a growing emphasis on early detection biomarkers, the integration of artificial intelligence (AI) in data analysis, the prominence of circulating tumor DNA (ctDNA) analysis, the expansion of companion diagnostics for targeted therapies, and a heightened focus on immunotherapy biomarkers. These trends are poised to shape and drive the continued expansion of colorectal cancer molecular diagnostics in the forecasted period.

The anticipated surge in inflammatory bowel diseases (IBD) incidence is forecasted to be a significant driver propelling the growth of the colorectal cancer molecular diagnostic market. IBD comprises chronic gastrointestinal disorders marked by inflammation in the digestive tract, particularly impacting the colon and rectum. The increased prevalence of IBD necessitates accurate and advanced diagnostic solutions, crucial for determining systemic therapy for colorectal cancer (CRC). Molecular assessment of tumors heavily influences treatment decisions, driving demand for efficient diagnostic solutions. According to BioMed Central Ltd. in May 2021, IBD cases are expected to rise substantially, reaching around 69,000 in Iran, 220,000 in the Middle East, 2.2 million in India, and a notable 4.5 million in East Asia from 2020 to 2035. Hence, the escalating IBD incidences are poised to propel growth within the colorectal cancer molecular diagnostic market.

The escalating prevalence of colorectal cancer is forecasted to drive the growth of the colorectal cancer molecular diagnostics market. Colorectal cancer affects the colon or rectum, resulting from the uncontrolled growth of cells in these digestive system areas, leading to tumor formation. The upsurge in colorectal cancer cases intensifies the demand for molecular diagnostic tools crucial in cancer detection and treatment. As highlighted by the American Cancer Society in March 2023, an estimated 153,020 individuals are anticipated to receive a colorectal cancer diagnosis, with around 52,550 projected deaths. This forecast includes 19,550 cases and 3,750 deaths among individuals under 50 years old. Thus, the rising prevalence of colorectal cancer is a key driver fueling growth within the colorectal cancer molecular diagnostics market.

The reluctance of healthcare professionals to embrace advanced diagnostic technologies due to budget limitations and pricing pressures from leading product manufacturers is expected to pose a challenge, potentially restraining market growth. Despite the enhanced accuracy and efficiency offered by molecular diagnostic tools for colorectal cancer detection and monitoring, healthcare providers might be hesitant to invest in these costly technologies. For instance, as indicated by the National Health Service in February 2022, allocating $2.81 million (£2.3 billion) over three years to transform diagnostic services in England indicates the financial constraints faced. Consequently, this reluctance to adopt advanced diagnostic technologies due to financial limitations hampers the growth potential of the colorectal cancer molecular diagnostics market.

Major companies are dedicated to pioneering innovative solutions in molecular diagnostics and personalized medicine, exemplified by the introduction of the Shield Blood Test approach for early-stage colorectal cancer detection. Guardant Health, a prominent US-based biotechnology company specializing in oncology molecular diagnostic products, launched the Shield Blood Test in May 2022. This groundbreaking blood test offers a convenient screening method involving a simple blood draw, addressing challenges associated with patient reluctance to undergo screening. The test demonstrated a sensitivity of 91% for detecting colorectal cancer and 20% for identifying advanced adenomas, with a specificity of 92%. Leveraging data from diverse cohorts comprising over 2,000 individuals with colorectal cancer, 357 with advanced adenoma, and 3,757 healthy subjects, the Shield test identifies early signals of colorectal cancer in the blood.

In July 2023, New Day Diagnostics LLC, a reputable US-based medical equipment manufacturing company, completed the acquisition of Epigenomics AG assets for an undisclosed sum. This strategic acquisition broadens New Day Diagnostics' portfolio in the realm of cancer diagnostics by acquiring intellectual property from Epigenomics AG. Notably, the acquisition includes Epi ProColon, an innovative screening technology specifically designed for the non-invasive detection of colorectal cancer. Epigenomics AG, headquartered in Germany, is a recognized player in the field of colorectal cancer molecular diagnostics, emphasizing the development of cutting-edge technologies for cancer detection.

Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.

North America was the largest region in the colorectal cancer molecular diagnostics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the colorectal cancer molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The colorectal cancer molecular diagnostics market consists of revenues earned by entities by providing diagnostic genetic mutation analysis, biomarker profiling, and epigenetic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal cancer molecular diagnostics market consists of sales of molecular diagnostic biochips, liquid biopsy kits, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Molecular Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colorectal cancer molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer molecular diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Instruments; Reagents And Kits; Services
• 2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
• 3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
• Companies Mentioned: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Molecular Diagnostics Market Characteristics

3. Colorectal Cancer Molecular Diagnostics Market Trends And Strategies

4. Colorectal Cancer Molecular Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Colorectal Cancer Molecular Diagnostics Market Size and Growth

• 5.1. Global Colorectal Cancer Molecular Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Colorectal Cancer Molecular Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Colorectal Cancer Molecular Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Colorectal Cancer Molecular Diagnostics Market Segmentation

• 6.1. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Instruments
• Reagents And Kits
• Services
• 6.2. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Polymerase Chain Reaction (PCR)
• Sequencing
• Mass Spectrometry
• Transcription Mediated Amplification
• Chips And Microarrays
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• 6.3. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Homecare Settings

7. Colorectal Cancer Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market

• 8.1. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Colorectal Cancer Molecular Diagnostics Market

• 9.1. China Colorectal Cancer Molecular Diagnostics Market Overview
• 9.2. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Colorectal Cancer Molecular Diagnostics Market

• 10.1. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Colorectal Cancer Molecular Diagnostics Market

• 11.1. Japan Colorectal Cancer Molecular Diagnostics Market Overview
• 11.2. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Colorectal Cancer Molecular Diagnostics Market

• 12.1. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Colorectal Cancer Molecular Diagnostics Market

• 13.1. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Colorectal Cancer Molecular Diagnostics Market

• 14.1. South Korea Colorectal Cancer Molecular Diagnostics Market Overview
• 14.2. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Colorectal Cancer Molecular Diagnostics Market

• 15.1. Western Europe Colorectal Cancer Molecular Diagnostics Market Overview
• 15.2. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Colorectal Cancer Molecular Diagnostics Market

• 16.1. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Colorectal Cancer Molecular Diagnostics Market

• 17.1. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Colorectal Cancer Molecular Diagnostics Market

• 18.5. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Colorectal Cancer Molecular Diagnostics Market

• 19.9. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Colorectal Cancer Molecular Diagnostics Market

• 20.13. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Colorectal Cancer Molecular Diagnostics Market

• 21.1. Eastern Europe Colorectal Cancer Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Colorectal Cancer Molecular Diagnostics Market

• 22.1. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Colorectal Cancer Molecular Diagnostics Market

• 23.1. North America Colorectal Cancer Molecular Diagnostics Market Overview
• 23.2. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Colorectal Cancer Molecular Diagnostics Market

• 24.1. USA Colorectal Cancer Molecular Diagnostics Market Overview
• 24.2. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Colorectal Cancer Molecular Diagnostics Market

• 25.1. Canada Colorectal Cancer Molecular Diagnostics Market Overview
• 25.2. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Colorectal Cancer Molecular Diagnostics Market

• 26.1. South America Colorectal Cancer Molecular Diagnostics Market Overview
• 26.2. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Colorectal Cancer Molecular Diagnostics Market

• 27.1. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Colorectal Cancer Molecular Diagnostics Market

• 28.1. Middle East Colorectal Cancer Molecular Diagnostics Market Overview
• 28.2. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Colorectal Cancer Molecular Diagnostics Market

• 29.1. Africa Colorectal Cancer Molecular Diagnostics Market Overview
• 29.2. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape
• 30.2. Colorectal Cancer Molecular Diagnostics Market Company Profiles
  • 30.2.1. Johnson & Johnson
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Laboratories
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Danaher Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Becton Dickinson and Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Colorectal Cancer Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. Biocartis Group NV
• 31.2. Agilent Technologies Inc.
• 31.3. Grifols S.A
• 31.4. Hologic Inc.
• 31.5. Biomerieux SA
• 31.6. Quidel Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Qiagen N.V.
• 31.9. Exact Sciences Corporation
• 31.10. Illumina Inc.
• 31.11. Cepheid
• 31.12. Myriad Genetics Inc.
• 31.13. Guardant Health
• 31.14. Luminex Corporation
• 31.15. GenMark Diagnostics

32. Global Colorectal Cancer Molecular Diagnostics Market Competitive Benchmarking

33. Global Colorectal Cancer Molecular Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market

35. Colorectal Cancer Molecular Diagnostics Market Future Outlook and Potential Analysis

• 35.1 Colorectal Cancer Molecular Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Colorectal Cancer Molecular Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Colorectal Cancer Molecular Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer